A Total Artificial Heart (TAH), to replace complete function of a patient’s failing heart

Visit Website Scroll Down

Bivacor’s Total Artificial Heart (TAH) has the potential to revolutionize the treatment of end-stage heart failure. It offers the potential of a permanent solution for patients suffering from this debilitating condition, providing them with full cardiac support and the ability to live a more normal life.

The TAH’s innovative combination of magnetic levitation technology and artificial intelligence allows it to replicate the natural pumping action of a healthy heart, improving blood flow and reducing the symptoms of heart failure. It also aims to bridge the patient to transplant, potentially extending their life.

This device represents a significant step forward in the field of medical technology, offering hope to patients with end-stage heart failure and their families, and has the potential to change the lives of thousands of people in need of a heart transplant.

Employment Hero
15 April 2022
18 May 2022
decor decor decor
decor decor decor decor decor